top of page
  • National Biologics Facility

Accelerating the pipeline of antiviral biologics to strengthen pandemic preparedness

The National Biologics Facility is excited to be working with Dr Adam Wheatly and team from the Doherty Institute to deliver new platforms to discover, optimise and validate the protective potential of human or humanised biologics as potent antiviral drugs for treatment or prevention of viral infectious diseases. Dr Wheatly and team were awarded $1.5 million in funding from Round One of the Foundation Grants from the Cumming Global Centre for Pandemic Therapeutics for this work.

Co-investigators: Professor Kanta Subbarao, Dr Danielle Anderson, Dr Jennifer Juno, Dr Nick Gheradin, Professor Florian Schmidt, Mr Ben Hughes, Dr Martina Jones, Dr Hyon-Xhi Tan, Professor Stephen Kent and Dr Claire L Gordon.

See more details about the Round One recipients here.


bottom of page